EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Sinonasal Plasmablastic Lymphoma: A Systematic Review

Sophia Chen, Haidee Chen, Sophie Song, Marilene B Wang

Journal of Neurological Surgery Reports · 01.10.2024 · 85 (04) · e167-e177

DOI: 10.1055/a-2444-3438 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Neurological Surgery Reports, erschienen am 01.10.2024. Verfasst von Sophia Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, UCLA Health, Los Angeles, California, United States. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Plasmablastic lymphoma (PBL) is a type of non-Hodgkin's B-cell lymphoma associated with human immunodeficiency virus and Epstein–Barr virus, commonly located in the oral cavity or gastrointestinal tract. Sinonasal involvement is rare, and there is no consensus on treatment. Data Sources Peer-reviewed published articles served as data sources. Review Methods A systematic review was conducted of the PubMed database for all cases of sinonasal PBL between 1978 and 2023 with the phrase “plasmablastic lymphoma.” Studies not written in English and that did not separate individual cases of sinonasal PBL from aggregated data were excluded. Age, sex, immune status, treatment, and outcomes were collected.

Conclusion

PBL is a rare malignancy in the sinonasal region usually treated with chemotherapy. It most commonly occurs in immunocompromised adults but has also been diagnosed in immunocompromised children and in immunocompetent adults. It is aggressive and has a poor prognosis.

Implications for Practice

PBL is a recently described entity with few cases of the sinonasal anatomic variant in the literature. Sinonasal PBL was most frequently treated with chemotherapy alone, closely followed by chemoradiation. The most common chemotherapy regimen utilized in the literature is cyclophosphamide, doxorubicin, oncovin/vincristine, and prednisone, which is also the most common chemotherapy regimen in nonsinonasal PBL. A second commonly used regimen is cyclophosphamide, vincristine/oncovin, doxorubicin/adriamycin, and dexamethasone. However, no treatment has emerged as superior to others with regard to survival. Further data are needed to better understand this rare disease.

Schlagwörter

Stichwörter der Autor:innen

diffuse large B-cell lymphomanon-Hodgkin's lymphomaplasmablastic lymphomasinonasal lymphomasinonasal neoplasm

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, UCLA Health, Los Angeles, California, United States.
  • David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
  • Department of Pathology and Laboratory Medicine, UCLA Health, Los Angeles, California, United States.

Zitieren

APA

Chen, S., Chen, H., Song, S., & Wang, M. B. (2024). Sinonasal Plasmablastic Lymphoma: A Systematic Review. Journal of Neurological Surgery Reports, 85(04), e167-e177. https://doi.org/10.1055/a-2444-3438

Vancouver

Chen S, Chen H, Song S, Wang MB. Sinonasal Plasmablastic Lymphoma: A Systematic Review. Journal of Neurological Surgery Reports. 2024;85(04):e167-e177. doi:10.1055/a-2444-3438

BibTeX
@article{Chen2024,
  author = {Chen, Sophia and Chen, Haidee and Song, Sophie and Wang, Marilene B},
  title = {Sinonasal Plasmablastic Lymphoma: A Systematic Review},
  journal = {Journal of Neurological Surgery Reports},
  year = {2024},
  volume = {85},
  number = {04},
  pages = {e167--e177},
  doi = {10.1055/a-2444-3438}
}
Kostenlos starten →